Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

Omega-3 fatty acid supplementation increases 1,25-dihydroxyvitamin D and fetuin-A levels in dialysis patients.

An WS, Lee SM, Son YK, Kim SE, Kim KH, Han JY, Bae HR, Rha SH, Park Y.

Nutr Res. 2012 Jul;32(7):495-502. doi: 10.1016/j.nutres.2012.06.005. Epub 2012 Jul 20.

PMID:
22901557
2.

Effect of omega-3 fatty acids on the modification of erythrocyte membrane fatty acid content including oleic acid in peritoneal dialysis patients.

An WS, Lee SM, Son YK, Kim SE, Kim KH, Han JY, Bae HR, Park Y.

Prostaglandins Leukot Essent Fatty Acids. 2012 Jan-Feb;86(1-2):29-34. doi: 10.1016/j.plefa.2011.10.009. Epub 2011 Nov 8.

PMID:
22071008
3.

Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients.

An WS, Kim SE, Kim KH, Lee S, Park Y, Kim HJ, Vaziri ND.

J Ren Nutr. 2009 Jul;19(4):267-74. doi: 10.1053/j.jrn.2009.01.027.

PMID:
19539181
4.

Association between vascular calcification scores on plain radiographs and fatty acid contents of erythrocyte membrane in hemodialysis patients.

Son YK, Lee SM, Kim SE, Kim KH, Lee SY, Bae HR, Han JY, Park Y, An WS.

J Ren Nutr. 2012 Jan;22(1):58-66. doi: 10.1053/j.jrn.2011.01.023. Epub 2011 May 26.

PMID:
21620727
5.

Comparison of erythrocyte membrane fatty acid contents in renal transplant recipients and dialysis patients.

Oh JS, Kim SM, Sin YH, Kim JK, Park Y, Bae HR, Son YK, Nam HK, Kang HJ, An WS.

Transplant Proc. 2012 Dec;44(10):2932-5. doi: 10.1016/j.transproceed.2012.04.041. Epub 2012 Nov 6.

PMID:
23195000
7.

Serum fetuin-A and vitamin D in children with mild-to-severe chronic kidney disease: a cross-sectional study.

Schaible J, Wigger M, Staude H, Drueckler E, Kundt G, Haffner D, Fischer DC.

Nephrol Dial Transplant. 2012 Mar;27(3):1107-13. doi: 10.1093/ndt/gfr382. Epub 2011 Jul 12.

8.

Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.

Freund Levi Y, Vedin I, Cederholm T, Basun H, Faxén Irving G, Eriksdotter M, Hjorth E, Schultzberg M, Vessby B, Wahlund LO, Salem N Jr, Palmblad J.

J Intern Med. 2014 Apr;275(4):428-36. doi: 10.1111/joim.12166. Epub 2014 Jan 11.

9.

Effects of protein and omega-3 supplementation, provided during regular dialysis sessions, on nutritional and inflammatory indices in hemodialysis patients.

Daud ZA, Tubie B, Adams J, Quainton T, Osia R, Tubie S, Kaur D, Khosla P, Sheyman M.

Vasc Health Risk Manag. 2012;8:187-95. doi: 10.2147/VHRM.S28739. Epub 2012 Mar 20.

10.

Relationship between vitamin D receptor gene FokI and ApaI polymorphisms and serum levels of fetuin-A, vitamin D, and parathyroid hormone in patients on hemodialysis.

Ghorbanihaghjo A, Argani H, Samadi N, Valizadeh S, Halajzadeh J, Yousefi B, Rashtchizadeh N.

Iran J Kidney Dis. 2014 Sep;8(5):394-400.

11.

Plasma fatty acid composition in continuous ambulatory peritoneal dialysis patients: an increased omega-6/omega-3 ratio and deficiency of essential fatty acids.

Yerlikaya FH, Mehmetoglu I, Kurban S, Tonbul Z.

Ren Fail. 2011;33(8):819-23. doi: 10.3109/0886022X.2011.601831. Epub 2011 Jul 28.

PMID:
21793790
12.

Vitamin D deficiency and associated factors in hemodialysis patients.

Jean G, Charra B, Chazot C.

J Ren Nutr. 2008 Sep;18(5):395-9. doi: 10.1053/j.jrn.2008.04.003.

PMID:
18721733
13.

Effects of oral supplementation with omega-3 fatty acids on nutritional state and inflammatory markers in maintenance hemodialysis patients.

Gharekhani A, Khatami MR, Dashti-Khavidaki S, Razeghi E, Abdollahi A, Hashemi-Nazari SS, Mansournia MA.

J Ren Nutr. 2014 May;24(3):177-85. doi: 10.1053/j.jrn.2014.01.014. Epub 2014 Mar 7.

PMID:
24613294
14.

The effects of omega-3 fatty acid on vitamin D activation in hemodialysis patients: a pilot study.

Lee SM, Son YK, Kim SE, An WS.

Mar Drugs. 2015 Jan 28;13(2):741-55. doi: 10.3390/md13020741.

16.

Effects of omega-3 polyunsaturated fatty acid supplementation on serum fetuin-A levels in type 2 diabetic patients.

Ozyazgan S, Karaoglu K, Kurt A, Altinok A, Konukoglu D, Osar Siva Z, Andican G.

Minerva Med. 2013 Jun;104(3):287-93.

PMID:
23748282
17.

The content of docosahexaenoic acid in serum phospholipid is inversely correlated with plasma homocysteine levels in patients with end-stage renal disease.

Rasmussen LE, Svensson M, Jørgensen KA, Schmidt EB, Christensen JH.

Nutr Res. 2010 Aug;30(8):535-40. doi: 10.1016/j.nutres.2010.07.004.

PMID:
20851307
18.

Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism.

Bucharles S, Barberato SH, Stinghen AE, Gruber B, Piekala L, Dambiski AC, Custodio MR, Pecoits-Filho R.

J Ren Nutr. 2012 Mar;22(2):284-91. doi: 10.1053/j.jrn.2011.07.001. Epub 2011 Sep 10.

PMID:
21908203
19.

Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease.

Kanbay M, Nicoleta M, Selcoki Y, Ikizek M, Aydin M, Eryonucu B, Duranay M, Akcay A, Armutcu F, Covic A.

Clin J Am Soc Nephrol. 2010 Oct;5(10):1780-6. doi: 10.2215/CJN.02560310. Epub 2010 Jun 24.

20.

Blood docosahexaenoic acid and eicosapentaenoic acid in vegans: Associations with age and gender and effects of an algal-derived omega-3 fatty acid supplement.

Sarter B, Kelsey KS, Schwartz TA, Harris WS.

Clin Nutr. 2015 Apr;34(2):212-8. doi: 10.1016/j.clnu.2014.03.003. Epub 2014 Mar 14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk